Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Innoviva, Inc. Director's Dealing 2011

Jun 17, 2011

32090_dirs_2011-06-17_a72612bd-e11a-4ca5-ac51-37d822cebda8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2011-06-17

Reporting Person: LEVINE ARNOLD J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-06-17 Common Stock J 20028 Acquired 73988 Direct

Footnotes

F1: The reporting person received a distribution of shares of the issuer's common stock under the terms of the Arnold J. Levine Grantor Retained Annuity Trust (GRAT). The closing stock price of the issuer's common stock on June 15, 2011 was used for purposes of calculating the number of shares distributed to the reporting person under the GRAT.